Latest Nerve Stories
AxoGen is the only regenerative medicine company that is completely focused on peripheral nerve repair MOUNTAIN VIEW, Calif., Jan.
Suppressing the enzyme fidgetin promotes the re-growth of experimentally injured nerve cells and their connections.
Partnership with City of Burleson to Support Growing Adoption of AxoGen’s Peripheral Nerve Repair Products Alachua, FL (PRWEB) December 10, 2013 AxoGen,
Peripheral Nerve Repair Company demonstrates growth to qualify for Technology Fast 500™ List Alachua, FL (PRWEB) November 14, 2013 AxoGen, Inc.
Researchers at Washington University School of Medicine in St. Louis have identified a chain reaction that triggers the regrowth of some damaged nerve cell branches, a discovery that one day may help improve treatments for nerve injuries that can cause loss of sensation or paralysis.
Company to feature portfolio of products for peripheral nerve repair, protection and regeneration at AAOMS Annual Meeting Alachua, FL (PRWEB) October 09, 2013
Includes updated data from RANGER® Registry and physician presentations on nerve repair with AxoGen products Alachua, FL (PRWEB) October 03, 2013
Education events at ASSH 2013 to feature presentations by clinical experts who are redefining expectations for peripheral nerve repair and protection Alachua,
Report estimates transected peripheral nerve repair in the US at $1.68 billion, quantifies markets services by AxoGen, Inc. Alachua,FL (PRWEB) September 20,
Exercise follows public offering and generates $18.6 million in proceeds Alachua, FL (PRWEB) September 11, 2013 AxoGen, Inc.
- The governor of a province or people.